ImageneBio, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $34.8M | $227.7M | $46.9M |
| Jun 2022 | $36.8M | $211.2M | $48.5M |
| Sep 2022 | $31.7M | $190.5M | $67.1M |
| Dec 2022 | $25.3M | $172.3M | $59.9M |
| Mar 2023 | $17.4M | $152.4M | $29.3M |
| Jun 2023 | $15.1M | $171.8M | $70.9M |
| Sep 2023 | $28.1M | $215.3M | $121.3M |
| Dec 2023 | $22.3M | $192.1M | $119.9M |
| Mar 2024 | $17.4M | $172.8M | $52.9M |
| Jun 2024 | $14.6M | $157.5M | $44.3M |
| Sep 2024 | $14.8M | $149.0M | $45.2M |
| Dec 2024 | $17.4M | $15.9M | $12.1M |
| Mar 2025 | $12.6M | $130.8M | $36.8M |
| Jun 2025 | $10.3M | $126.2M | $58.3M |
| Sep 2025 | $21.0M | $160.9M | $103.2M |
| Dec 2025 | $19.8M | $153.0M | $94.5M |
| Mar 2026 | $13.4M | $136.7M | $76.0M |
| Jun 2026 | $10.0M | $152.0M | $94.7M |